AC Immune S.A.ACIUNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q3 2025 | -15.17% |
| Q2 2025 | -21.33% |
| Q1 2025 | -7.44% |
| Q4 2024 | -21.76% |
| Q3 2024 | 5.15% |
| Q2 2024 | -14.83% |
| Q1 2024 | -23.75% |
| Q4 2023 | 27.84% |
| Q3 2023 | -9.81% |
| Q2 2023 | -8.90% |
| Q1 2023 | -10.09% |
| Q4 2022 | -11.08% |
| Q3 2022 | -11.13% |
| Q2 2022 | -5.29% |
| Q1 2022 | -7.69% |
| Q4 2021 | 19.92% |
| Q3 2021 | -5.32% |
| Q2 2021 | -8.74% |
| Q1 2021 | -5.72% |
| Q4 2020 | -7.63% |
| Q3 2020 | -7.09% |
| Q2 2020 | -5.56% |
| Q1 2020 | -2.51% |
| Q4 2019 | -6.87% |
| Q3 2019 | 4.89% |
| Q2 2019 | 9.00% |
| Q1 2019 | 36.16% |
| Q4 2018 | -12.33% |
| Q3 2018 | 79.55% |
| Q2 2018 | -9.95% |
| Q1 2018 | -9.58% |
| Q4 2017 | 3.51% |
| Q3 2017 | -6.99% |
| Q2 2017 | -9.45% |
| Q1 2017 | -7.29% |
| Q4 2016 | -14.47% |
| Q3 2016 | 80.56% |
| Q2 2016 | 39.99% |
| Q1 2016 | -8.96% |
| Q4 2015 | 38.07% |